R.O. Mirimanoff - Concepedia

Author

R.O. Mirimanoff

Also Known As

R MIRIMANOFF, R O Mirimanoff, R. Mirimanoff, R. O. Mirimanoff, R.-O. Mirimanoff, R.O Mirimanoff, R.O. Mirimanoff, Rene Mirimanoff, Rene O Mirimanoff, Rene O. Mirimanoff

120

Publications

35.3K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Lausanne European Organisation for Research and Treatment of Cancer University of Lausanne Erasmus MC University of Calgary

About

R.O. Mirimanoff is an author at University Hospital of Lausanne specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	4.3K
2	Health Sciences	10	10	1.4K
3	Engineering	1	1	25
4	Biostatistics	1	1	543
5	Emergency Medicine	1	1	35

R.O. Mirimanoff

Publications

34.3K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, New England Journal of Medicine	2005	7.1K
Meningioma: analysis of recurrence and progression following neurosurgical resection R.O. Mirimanoff, Daniel E. Dosoretz, Rita M. Linggood, Journal of neurosurgery Neuro-oncologySubtotal ExcisionSurgical OncologyRadiologyMedicine	1985	1.1K
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, Journal of Clinical Oncology	2002	812
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 Thierry Gorlia, Martin J. van den Bent, Monika E. Hegi, The Lancet Oncology Neuro-oncologyPrognostic BiomarkersGliomaNcic TrialPrognostic Factor Analysis	2007	543
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients L. Claassens, Neil K. Aaronson, Corneel Coens, European Journal of Cancer Quality Of LifeNeuro-oncologyInternational Validation StudyLife AssessmentMedicine	2010	381
Health-related quality of life in patients with glioblastoma: a randomised controlled trial Roger Stupp, Corneel Coens, David Osoba, The Lancet Oncology Quality Of LifeNeuro-oncologyLife AssessmentHealth PolicyHealth-related Quality	2005	328
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma Michael Weller, Thierry Gorlia, J. G. Cairncross, Neurology	2011	291
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy Antony Lomax, Thomas Bortfeld, Gudrun Goitein, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineRadiation TherapyTreatment VerificationPhoton Radiotherapy	1999	235
Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer Network S. Bijmolt, Theo Veninga, N. Rezvoy, International Journal of Radiation OncologyBiologyPhysics Retrospective StudyNeuro-oncologySurgical OncologyRare Cancer NetworkTumoral Pathology	2008	231

Page 1